Argus Research Maintains Buy on Versigent, Raises Price Target to $54
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Argus Research analyst Bill Selesky maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $50 to $54.
Argus Research analyst Bill Selesky maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $50 to $54.